KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Leases (2019 - 2025)

Twist Bioscience (TWST) has disclosed Leases for 5 consecutive years, with $72.0 million as the latest value for Q2 2023.

  • On a quarterly basis, Leases fell 5.43% to $72.0 million in Q2 2023 year-over-year; TTM through Jun 2023 was $72.0 million, a 5.43% decrease, with the full-year FY2022 number at $74.9 million, up 21.71% from a year prior.
  • Leases was $72.0 million for Q2 2023 at Twist Bioscience, up from $70.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $78.2 million in Q1 2022 to a low of $31.0 million in Q1 2021.
  • A 5-year average of $56.5 million and a median of $62.8 million in 2021 define the central range for Leases.
  • Peak YoY movement for Leases: dropped 13.54% in 2021, then soared 152.33% in 2022.
  • Twist Bioscience's Leases stood at $37.2 million in 2019, then decreased by 13.18% to $32.3 million in 2020, then soared by 122.77% to $72.0 million in 2021, then rose by 2.41% to $73.8 million in 2022, then decreased by 2.34% to $72.0 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Leases are $72.0 million (Q2 2023), $70.7 million (Q1 2023), and $73.8 million (Q4 2022).